Magnesium sulfate as a tocolytic agent

Semin Perinatol. 2001 Aug;25(4):236-47. doi: 10.1053/sper.2001.27546.

Abstract

Although magnesium sulfate is widely used as a tocolytic agent in the hope of preventing spontaneous preterm birth, there is a paucity of data from large well-designed randomized clinical studies demonstrating the efficacy of magnesium sulfate therapy. Given the potential for untoward side effects and the inherent risks of magnesium sulfate therapy, a thorough understanding of the potential risks and benefits of this agent is needed. To accomplish this understanding we have provided a detailed review the history, pharmacology, physiology, maternal/fetal side effects, and tocolytic efficacy of magnesium sulfate.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use
  • Female
  • Fetal Diseases / chemically induced
  • Humans
  • Magnesium Sulfate / adverse effects
  • Magnesium Sulfate / pharmacokinetics
  • Magnesium Sulfate / therapeutic use*
  • Maternal-Fetal Exchange
  • Obstetric Labor, Premature / prevention & control*
  • Pregnancy
  • Tocolytic Agents / therapeutic use*

Substances

  • Adrenergic beta-Agonists
  • Tocolytic Agents
  • Magnesium Sulfate